A PHASE-III RANDOMIZED COMPARISON OF MDL (METOCLOPRAMIDE, DEXAMETHASONE, AND LORAZEPAM) PLUS GRANISETRON WITH MDL ALONE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MULTI-DAY CISPLATIN-CONTAINING CHEMOTHERAPY

Citation
Yk. Kang et al., A PHASE-III RANDOMIZED COMPARISON OF MDL (METOCLOPRAMIDE, DEXAMETHASONE, AND LORAZEPAM) PLUS GRANISETRON WITH MDL ALONE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MULTI-DAY CISPLATIN-CONTAINING CHEMOTHERAPY, European journal of cancer, 31A, 1995, pp. 1238-1238
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
31A
Year of publication
1995
Supplement
5
Pages
1238 - 1238
Database
ISI
SICI code
0959-8049(1995)31A:<1238:APRCOM>2.0.ZU;2-6